CRISPR Therapeutics CRSP 深 沪
等待开盘 10-16 09:30:00 美东时间
51.52
+1.300
+2.59%
华盛通- 最 高52.3725
- 今 开50.00
- 成交量 135.29万股
- 最 低 49.76
- 昨 收 50.22
- 总市值 49.82亿
- 52周最高 67.73
- 市盈率 静 --
- 换手率 1.40%
- 52周最低 44.12
- 委 比 79.53%
- 总股本 9669.27万
- 历史最高 220.20
- 量 比 0.80
- 振 幅 5.20%
- 历史最低 13.50
- 每 手 1
- 风险率 4.85%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅279.75%！Jones Trading维持Contineum Therapeutics(CTNM)"买入"评级，目标价上调至30美元
今日重点评级关注：Jones Trading：维持Contineum Therapeutics"买入"评级，目标价从24美元升至30美元；StoneX：维持Forum Markets"投机性买入"评级，目标价从9美元升至12美元
今天 12:30
Jim Cramer Is ‘Monster Long’ On Mark Zuckerberg’s Meta On Muse Retention, But Cathie Wood Trims $3.36 Million Stake
On Monday, Cathie Wood-led Ark Invest trimmed its position in Meta Platforms Inc. (NASDAQ:META), while adding shares of several biotechnology companies. The Meta Platforms Trade Ark sold 4,520 Meta shares through the ARK Innovation ETF (BATS:ARKK) on Monday. Based on Meta stock closing at $742.96, t...
10-13 09:41
CRISPR Therapeutics to Present Clinical Data on Zugocabtagene Geleucel (Zugo-cel) in Autoimmune Disease at the American College of Rheumatology (ACR) Convergence 2026
CRISPR Therapeutics announced that it will present Phase 1 clinical data for its investigational CRISPR/Cas9 gene-edited allogeneic CAR T cell therapy, zugocabtagene geleucel (zugo-cel), targeting CD19 for autoimmune diseases, at the American College of Rheumatology (ACR) Convergence 2026. The poster presentation, titled "Safety and Efficacy of Anti-CD19 Allogeneic Chimeric Antigen Receptor (CAR) T Cell Therapy Zugocabtagene Geleucel (zugo-cel) i...
10-02 14:15
Insider trades: Nvidia, Oracle, Salesforce among notable names
This week, insider transactions were seen across major technology companies, including Nvidia (NVDA), Oracle (ORCL), and Salesforce (CRM). The following transactions took place between September 21 an...
09-26 23:03
Anthropic IPO前亮科研牌：Claude“自主发现”类CRISPR系统，基因编辑板块遭遇“AI替代焦虑”
周三，美股基因编辑公司股价走低。此前，Anthropic宣布，其AI模型Claude“自主发现”了一种类似于基因编辑工具CRISPR的新型酶系统。 个股方面，...
09-24 07:21
Gene editing stocks fall after Anthropic’s CRISPR-like discovery
Gene editing companies traded lower on Wednesday after Anthropic (ANTHRO) said that its AI model Claude has “autonomously discovered” a new enzyme system similar to the gene-editing tool CRISPR. Notab...
09-24 02:33
CRISPR Therapeutics shares are trading lower after reports that Anthropic's Biolab has discovered a new enzyme system that resembles the Crispr gene editing tool.
CRISPR Therapeutics shares are trading lower after reports that Anthropic's Biolab has discovered a new enzyme system that resembles the Crispr gene editing tool.
09-24 02:10
CRISPR Therapeutics set to snap six-session losing streak
CRISPR Therapeutics (CRSP) is set to snap six straight sessions of losses, as the stock was up more than 3% at $53.32 on Monday. The company lost 8.5% over the past six sessions. The stock closed 1.03...
09-15 01:06
Cathie Wood's Ark weekly recap: buys Meta, gene-editing stocks while cutting Alphabet
Cathie Wood’s Ark Invest stepped up bets on biotechnology and AI during the last week, with Meta Platforms (META) and a group of gene-editing companies among its biggest purchases, while cutting expos...
09-14 19:10
Cathie Wood Says AI Revolution Could Supercharge Global Growth — TSLA, COIN and CRSP Stocks Are Among Her Top Bets
ARK Invest CEO Cathie Wood says the ongoing technological shift mirrors the Industrial Revolution. Outlining her macroeconomic outlook, she said, “rapid real growth is where we’re going,” expecting the global real GDP growth rate to at least double in the coming years. The Five Innovation Platforms ...
09-07 14:46
